Literature DB >> 32878910

Combining Three-Dimensional Modeling with Artificial Intelligence to Increase Specificity and Precision in Peptide-MHC Binding Predictions.

Michelle P Aranha1,2, Yead S M Jewel1,2, Robert A Beckman3,4,5, Louis M Weiner5, Julie C Mitchell6, Jerry M Parks2,6, Jeremy C Smith7,2.   

Abstract

The reliable prediction of the affinity of candidate peptides for the MHC is important for predicting their potential antigenicity and thus influences medical applications, such as decisions on their inclusion in T cell-based vaccines. In this study, we present a rapid, predictive computational approach that combines a popular, sequence-based artificial neural network method, NetMHCpan 4.0, with three-dimensional structural modeling. We find that the ensembles of bound peptide conformations generated by the programs MODELLER and Rosetta FlexPepDock are less variable in geometry for strong binders than for low-affinity peptides. In tests on 1271 peptide sequences for which the experimental dissociation constants of binding to the well-characterized murine MHC allele H-2Db are known, by applying thresholds for geometric fluctuations the structure-based approach in a standalone manner drastically improves the statistical specificity, reducing the number of false positives. Furthermore, filtering candidates generated with NetMHCpan 4.0 with the structure-based predictor led to an increase in the positive predictive value (PPV) of the peptides correctly predicted to bind very strongly (i.e., K d < 100 nM) from 40 to 52% (p = 0.027). The combined method also significantly improved the PPV when tested on five human alleles, including some with limited data for training. Overall, an average increase of 10% in the PPV was found over the standalone sequence-based method. The combined method should be useful in the rapid design of effective T cell-based vaccines.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32878910      PMCID: PMC7511449          DOI: 10.4049/jimmunol.1900918

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles.

Authors:  O Schueler-Furman; Y Altuvia; A Sette; H Margalit
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

3.  Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs.

Authors:  P G GELL; B BENACERRAF
Journal:  Immunology       Date:  1959-01       Impact factor: 7.397

4.  A structure-based approach for prediction of MHC-binding peptides.

Authors:  Yael Altuvia; Hanah Margalit
Journal:  Methods       Date:  2004-12       Impact factor: 3.608

5.  DynaPred: a structure and sequence based method for the prediction of MHC class I binding peptide sequences and conformations.

Authors:  Iris Antes; Shirley W I Siu; Thomas Lengauer
Journal:  Bioinformatics       Date:  2006-07-15       Impact factor: 6.937

Review 6.  Prediction of MHC-peptide binding: a systematic and comprehensive overview.

Authors:  Esther M Lafuente; Pedro A Reche
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

7.  It's the peptide-MHC affinity, stupid.

Authors:  Thomas Kammertoens; Thomas Blankenstein
Journal:  Cancer Cell       Date:  2013-04-15       Impact factor: 31.743

8.  Relapse or eradication of cancer is predicted by peptide-major histocompatibility complex affinity.

Authors:  Boris Engels; Victor H Engelhard; John Sidney; Alessandro Sette; David C Binder; Rebecca B Liu; David M Kranz; Stephen C Meredith; Donald A Rowley; Hans Schreiber
Journal:  Cancer Cell       Date:  2013-04-15       Impact factor: 31.743

9.  HLA class I alleles are associated with peptide-binding repertoires of different size, affinity, and immunogenicity.

Authors:  Sinu Paul; Daniela Weiskopf; Michael A Angelo; John Sidney; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2013-11-04       Impact factor: 5.422

10.  Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.

Authors:  W Chen; S Khilko; J Fecondo; D H Margulies; J McCluskey
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  4 in total

1.  Promoting the formation of Pi-stacking interaction to improve CTL cells activation between modified peptide and HLA.

Authors:  Ying Zhu; Chang-Xin Huang; Le Zhang; Ze-Fang Wang; Dong-Li Zhao; Fei Ding; Si-Yu Zhang; Yong-Qiang Li; Ling-Zhi Chen
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  3pHLA-score improves structure-based peptide-HLA binding affinity prediction.

Authors:  Anja Conev; Didier Devaurs; Mauricio Menegatti Rigo; Dinler Amaral Antunes; Lydia E Kavraki
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

3.  Impact of Structural Observables From Simulations to Predict the Effect of Single-Point Mutations in MHC Class II Peptide Binders.

Authors:  Rodrigo Ochoa; Roman A Laskowski; Janet M Thornton; Pilar Cossio
Journal:  Front Mol Biosci       Date:  2021-03-30

Review 4.  T Cell Epitope Prediction and Its Application to Immunotherapy.

Authors:  Anna-Lisa Schaap-Johansen; Milena Vujović; Annie Borch; Sine Reker Hadrup; Paolo Marcatili
Journal:  Front Immunol       Date:  2021-09-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.